The Business Research Company’s global market reports are now updated with the latest market sizing
Read More
The Metagenomics In Healthcare market size is expected to reach $5.46 billion in 2030 at 17.5%, driven by increasing prevalence of infectious diseases.
Read More
Global Metagenomics market size is expected to reach $4.58 billion by 2030 at 14.58.7%, the impact of rising infectious disease incidence on the metagenomics market
Read More
Global Metagenomic Sequencing market size is expected to reach $5.14 billion by 2030 at 15.1%, segmented as by reagents and consumables, dna or rna extraction kits, library preparation kits, sequencing kits, pcr and qpcr reagents
Read More
The metabolomics services market is set to reach $5.97 billion by 2030, growing at 14.4% CAGR, driven by personalized medicine, AI analytics, and expanding drug discovery programs.
Read More
The metabolomics market is projected to reach $9.29 billion by 2030, growing at 17.3% CAGR, driven by precision medicine, AI-driven analytics, and expanding clinical diagnostics integration.
Read More
Global Metabolic Testing market size is expected to reach $0.91 billion by 2030 at 7.3%, increase in prevalence of chronic diseases is driving the market growth
Read More
Global Metabolic Syndrome market size is expected to reach $127.96 billion by 2030 at 7.2%, increasing prevalence of lifestyle diseases is driving the market growth
Read More
Global Metabolic Dysfunction-Associated Steatohepatitis (MASH) Treatment market size is expected to reach $8.6 billion by 2030 at 22%, rising obesity prevalence driving growth in the market
Read More
The metabolic biomarker testing market is projected to reach $4.54 billion by 2030, growing at 8.1% CAGR, driven by personalized diagnostics, AI-driven analysis, and preventive health screening.
Read More
The mesotherapy market is projected to reach $1.03 billion by 2030, growing at 10.3% CAGR, driven by personalized aesthetic treatments, minimally invasive procedures, and advanced injectable solutions.
Read More